NCT07058727

Brief Summary

This randomized clinical trial evaluates the efficacy of sodium hypochlorite (NaOCl), chlorhexidine (CHX), and cold saline as hemostatic agents in partial pulpotomy. The study compares postoperative pain (via VAS scores) and pulp survival (via clinical/radiographic evaluation) at 1, 3, 7 days, 6 months, and 12 months

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 19, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

July 10, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

April 1, 2026

Status Verified

March 1, 2026

Enrollment Period

6 months

First QC Date

June 19, 2025

Last Update Submit

March 27, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Postoperative Pain

    The patient will be asked to rate the pain on the 1st, 3rd and 7th day according to VAS. (The patient is asked to score their pain in this range, with 0 being the lowest and 10 being the highest.)

    1 week

  • Pulp Survival Rate

    The pulp is expected to be vital, without percussion tenderness and without spontaneous pain

    12 months

Secondary Outcomes (1)

  • Clinical Success

    12 months

Study Arms (3)

Arm 1

EXPERIMENTAL

2.5% NaOCl applied for 1 min after pulp exposure.

Drug: Sodium Hypochlorite 2,5%

Arm 2

EXPERIMENTAL

2% CHX applied for 1 min

Drug: Chlorhexidine

Arm 3

EXPERIMENTAL

Hemostasis achieved with 4°C saline for 1 min.

Drug: Cold Saline

Interventions

2% CHX applied for 1 min to achieve hemostasis, with identical subsequent steps to NaOCl group

Arm 2

2.5% NaOCl applied for 1 min to exposed pulp for hemostasis, followed by standard pulp capping

Arm 1

Hemostasis via 4°C saline (1 Min), then standardized pulp capping

Arm 3

Eligibility Criteria

Age15 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Permanent teeth with carious pulp exposure (no spontaneous pain).
  • Positive vitality test (Endo-Ice).
  • No periapical radiolucency.

You may not qualify if:

  • Systemic diseases affecting healing.
  • Pregnancy.
  • Non-vital pulp/necrosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Çukurova Üniversitesi Diş Hekimliği Fakültesi

Adana, Sarıçam, 01250, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Chlorhexidine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

BiguanidesGuanidinesAmidinesOrganic Chemicals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 19, 2025

First Posted

July 10, 2025

Study Start

May 1, 2025

Primary Completion

November 1, 2025

Study Completion

May 1, 2026

Last Updated

April 1, 2026

Record last verified: 2026-03

Locations